2-aminopyrazine has been researched along with Myositis Ossificans in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arista, L; Broennimann, V; Guth, S; Head, V; Kramer, I; Stiefl, N; Teixeira-Fouchard, S; Ullrich, T; Weiler, S | 1 |
1 other study(ies) available for 2-aminopyrazine and Myositis Ossificans
| Article | Year |
|---|---|
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva.
Topics: Activin Receptors, Type I; Humans; Myositis Ossificans; Ossification, Heterotopic; Pyrazines; Signal Transduction | 2022 |